Lack of evidence for bacterial infections in skin in patients with systemic sclerosis

American Journal of the Medical Sciences

Volumn 337, Issue 4, 2009, Pages 233-235

  Mayes, Maureen D ^a   Whittum Hudson, Judith A ^b   Oszust, Cynthia ^b   Gérard, Hervé C ^b   Hudson, Alan P ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C. pneumoniae; C. trachomatis; PCR based screening; Persistent bacterial infection; Systemic sclerosis

Indexed keywords

BACTERIAL DNA;

ADULT; AGED; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EVIDENCE BASED MEDICINE; FEMALE; GENE TARGETING; HUMAN; HUMAN TISSUE; MALE; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; POPULATION ABUNDANCE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; SKIN INFECTION; SYSTEMIC SCLEROSIS; BACTERIAL SKIN DISEASE; BIOPSY; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; BACTERIAL INFECTIONS; BIOPSY; DNA, BACTERIAL; FEMALE; HUMANS; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN DISEASES, BACTERIAL;

EID: 65549098150     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181891612     Document Type: Article

References (17)

1. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-567 (Pubitemid 46348510)
2. Guiducci S, Giacomelli R, Cerinic MM. Vascular complications of scleroderma. Autoimmun Rev 2007;6:520-523
3. Steen VD. Autoantibodies in systemic sclerosis. Sem Arthritis Rheum 2005;35:35-42.
4. Pandey JP, LeRoy EC. Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum 1998;41:10-15.
5. DeBoer OJ, van der Wal AC, Becker AE. Atherosclerosis, inflammation, and infection. J Pathol 2000;190:237-243
6. Epstein SE, Zhou YF, Shu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999;100:e20-e28.
7. Ho M, Veale D, Eastmond C, et al. Macrovascular disease and systemic sclerosis. Ann Rheum Diseases 2000;59:39-43.
8. Matucci-Cerinic M, Steen VD, Furst DE, et al. Clinical trials in systemic sclerosis: lesions learned and outcomes. Arthritis Res Ther 2007;9(suppl 2):S7-S15.
9. Whittum-Hudson JA, Hudson AP. Human chlamydial infections: persistence, prevalence, and prospects for the future. Nat Sci Soc 2005;13:371-382
10. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-590
11. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J. Rheumatol 1988;15:202-205 (Pubitemid 18073738)
12. Gérard HC, Whittum-Hudson JA, Schumacher HR, et al. Differential expression of the three Chlamydia trachomatis hsp60-encoding genes in active vs persistent infection. Microb Pathogen 2004;36:35-39.
13. Gérard HC, Branigan PJ, Schumacher HR, et al. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 1998;25:734-742
14. Gérard HC, Schumacher HR, El-Gabalawy H, et al. Chlamydia pneumoniae infecting the human synovium are viable and metabolically active. Microb Pathogen 2000;29:17-24.
15. Gérard HC, Wang Z, Wang GF, et al. Chromosomal DNA from a variety of bacterial species is present in synovial tissue in patients with various forms of arthritis. Arthritis Rheum 2001;44:1689-1697 (Pubitemid 32642232)
16. Ohtsuka T, Yamazaki S. Increased prevalence of human parvovirus B19 in systemic sclerosis skin. Brit J Dermatol 2004;150:1091-1095 (Pubitemid 38932277)
17. Ferri C, Cazzato M, Giuggioli D, et al. Systemic sclerosis following human cytomegalovirus infection. Ann Rheumat Dis 2002;61:937-938